Doug Treco Treco
Chief Executive Officer bei INOZYME PHARMA, INC.
Vermögen: 196 939 $ am 30.04.2024
Aktive Positionen von Doug Treco Treco
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CRISPR THERAPEUTICS AG | Director/Board Member | 11.06.2020 | - |
Independent Dir/Board Member | 11.06.2020 | - | |
INOZYME PHARMA, INC. | Chief Executive Officer | 01.04.2023 | - |
Chairman | 01.05.2020 | - | |
Independent Dir/Board Member | 01.05.2020 | - | |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Consultant / Advisor | - | - |
3CC Management LLC
3CC Management LLC Investment ManagersFinance 3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - | - |
Karriereverlauf von Doug Treco Treco
Ehemalige bekannte Positionen von Doug Treco Treco
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Alchemab Therapeutics Ltd.
Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Director/Board Member | 22.06.2021 | 26.05.2022 |
Chief Executive Officer | 22.06.2021 | 26.05.2022 | |
RA PHARMACEUTICALS, INC. | Director/Board Member | 27.06.2008 | 02.04.2020 |
Chief Executive Officer | 27.06.2008 | 01.07.2020 | |
Founder | 27.06.2008 | 01.07.2020 | |
President | 27.06.2008 | 01.07.2020 | |
Morgenthaler Management Corp.
Morgenthaler Management Corp. Investment ManagersFinance Morgenthaler Management Corp (Morgenthaler Management) is a venture capital and private equity firm founded in 1968 by David Morgenthaler. The firm is headquartered in Portola Valley, California. | Private Equity Investor | 20.01.2011 | 31.01.2014 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.01.1988 | 01.01.2005 |
Founder | 01.01.1988 | 01.01.2005 | |
Xcellerex, Inc.
Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Director/Board Member | - | - |
Ausbildung von Doug Treco Treco
Stony Brook University | Doctorate Degree |
University of Delaware | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Schweiz | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Founder | 2 |
Sektoral
Health Technology | 6 |
Finance | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
INOZYME PHARMA, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Xcellerex, Inc.
Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Health Technology |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Morgenthaler Management Corp.
Morgenthaler Management Corp. Investment ManagersFinance Morgenthaler Management Corp (Morgenthaler Management) is a venture capital and private equity firm founded in 1968 by David Morgenthaler. The firm is headquartered in Portola Valley, California. | Finance |
Alchemab Therapeutics Ltd.
Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Health Technology |
3CC Management LLC
3CC Management LLC Investment ManagersFinance 3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts. | Finance |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Finance |
- Börse
- Insiders
- Doug Treco Treco
- Erfahrung